account_id none on file
legal_name Acurx Pharmaceuticals, Inc.
ticker ACXP
cik 1736243
domain acurxpharma.com
linkedin_company_url https://www.linkedin.com/company/acurx-pharmaceuticals-inc
entry_point_account_id none on file
name Acurx Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 14 executives 8 family 0
why_nownone on file
callsnone on file
filings
David P. Luci 59 President, Chief Executive Officer and Director
filing / Sep 1, 2026 / receipt
Robert J. DeLuccia 81 Executive Chairman, Director
filing / Sep 1, 2026 / receipt
Carl V. Sailer 56 Director
filing / Sep 1, 2026 / receipt
Thomas Harrison 79 Director
filing / Sep 1, 2026 / receipt
Joseph C. Scodari 73 Director
filing / Sep 1, 2026 / receipt
Jack H. Dean 84 Director
filing / Sep 1, 2026 / receipt
James Donohue 57 Director
filing / Sep 1, 2026 / receipt
David P. Luci - President and Chief Executive Officer, Director
filing / Sep 1, 2026 / receipt
Robert Shawah - Chief Financial Officer
filing / Sep 1, 2026 / receipt
Robert J. DeLuccia, Executive Chairman of the Board and Director
filing / Sep 1, 2026 / receipt
David P. Luci and Jack H. Dean (Class II directors) with a term
filing / Sep 1, 2026 / receipt
Robert J. DeLuccia, Joseph C. Scodari and James Donohue (Class III directors)
filing / Sep 1, 2026 / receipt
executives
| Carl V. Sailer | Director | - | receipt |
| David P. Luci | President, Chief Executive Officer and Director | - | receipt |
| Jack H. Dean | Director | - | receipt |
| James Donohue | Director | - | receipt |
| Joseph C. Scodari | Director | - | receipt |
| Robert J. DeLuccia | Executive Chairman, Director | - | receipt |
| Robert Shawah | Chief Financial Officer | receipt | |
| Thomas Harrison | Director | - | receipt |
familynone on file
upcoming
| 2026-11-11 | earnings call | scheduled | ir |
changesnone on file
mcp_package_hint
slug acurx-pharmaceuticals-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$